ID: h-bcbc70473b
Hypothesis
GluN2B-CX3CL1 Axis Controls Microglial Tau Phagocytosis
GluN2B signaling in cortical excitatory neurons releases fractalkine (CX3CL1) via activity-dependent TACE/ADAM17 shedding.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
GluN2B signaling in cortical excitatory neurons releases fractalkine (CX3CL1) via activity-dependent TACE/ADAM17 shedding. CX3CL1 engages microglial CX3CR1 receptors, promoting TREM2-dependent phagocytosis of extracellular tau aggregates. Domain Expert recommends targeting downstream TREM2 rather than upstream GluN2B for superior druggability. Validated biomarker (CSF sTREM2) enables clinical development.
🧬 Mechanism
🔗 Mechanism from KG for GRIN2B → CX3CL1 → CX3CR1/TREM2 axis
Auto-built from this analysis's top knowledge-graph edges.
graph TD
GluN2B["GluN2B"] -->|regulates| thalamic_burst_firing["thalamic burst firing"]
slow_wave_oscillations["slow-wave oscillations"] -->|enhances| glymphatic_clearance["glymphatic_clearance"]
tau_pathology["tau_pathology"] -.->|inhibits| glymphatic_clearance_effi["glymphatic clearance efficiency"]
Trem2["Trem2"] -->|regulates| tau_phagocytosis["tau phagocytosis"]
TREM2_deficiency["TREM2 deficiency"] -->|associated with| Tau_Clearance["Tau Clearance"]
Cx3Cl1["Cx3Cl1"] -->|associated with| Cx3Cr1["Cx3Cr1"]
Cx3Cr1_1["Cx3Cr1"] -->|regulates| tau_phagocytosis_2["tau phagocytosis"]
Memantine["Memantine"] -->|enhances| CSF_tracer_clearance["CSF tracer clearance"]
GluN2B_3["GluN2B"] -->|associated with| cortical_slow_wave_oscill["cortical slow-wave oscillations"]
oxidative_stress["oxidative_stress"] -->|causes| AQP4_oxidation["AQP4 oxidation"]
GLUTAMATE_EXCITOTOXICITY["GLUTAMATE EXCITOTOXICITY"] -->|enhances| Tau_Secretion["Tau Secretion"]
sess_SRB_2026_04_28_h_var["sess_SRB-2026-04-28-h-var-e2b5a7e7db_task_9aae8fc5"] -->|causal extracted| processed["processed"]
style GluN2B fill:#4fc3f7,stroke:#333,color:#000
style thalamic_burst_firing fill:#4fc3f7,stroke:#333,color:#000
style slow_wave_oscillations fill:#4fc3f7,stroke:#333,color:#000
style glymphatic_clearance fill:#81c784,stroke:#333,color:#000
style tau_pathology fill:#ef5350,stroke:#333,color:#000
style glymphatic_clearance_effi fill:#4fc3f7,stroke:#333,color:#000
style Trem2 fill:#4fc3f7,stroke:#333,color:#000
style tau_phagocytosis fill:#4fc3f7,stroke:#333,color:#000
style TREM2_deficiency fill:#4fc3f7,stroke:#333,color:#000
style Tau_Clearance fill:#4fc3f7,stroke:#333,color:#000
style Cx3Cl1 fill:#4fc3f7,stroke:#333,color:#000
style Cx3Cr1 fill:#4fc3f7,stroke:#333,color:#000
style Cx3Cr1_1 fill:#4fc3f7,stroke:#333,color:#000
style tau_phagocytosis_2 fill:#4fc3f7,stroke:#333,color:#000
style Memantine fill:#ce93d8,stroke:#333,color:#000
style CSF_tracer_clearance fill:#ce93d8,stroke:#333,color:#000
style GluN2B_3 fill:#4fc3f7,stroke:#333,color:#000
style cortical_slow_wave_oscill fill:#4fc3f7,stroke:#333,color:#000
style oxidative_stress fill:#4fc3f7,stroke:#333,color:#000
style AQP4_oxidation fill:#4fc3f7,stroke:#333,color:#000
style GLUTAMATE_EXCITOTOXICITY fill:#4fc3f7,stroke:#333,color:#000
style Tau_Secretion fill:#4fc3f7,stroke:#333,color:#000
style sess_SRB_2026_04_28_h_var fill:#4fc3f7,stroke:#333,color:#000
style processed fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix3 supports2 contradicts
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — GRIN2B
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GRIN2B → CX3CL1 → CX3CR1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↘
Falling
7d Momentum
▼ 1.4%
Volatility
Low
0.0028
Events (7d)
3
Price History
▼18.5%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF we selectively overexpress CX3CL1 in cortical excitatory neurons of P301S tauopathy mice (via viral vector or transgenic approach), THEN we will observe a statistically significant increase in micr | Reduced CSF total tau by ≥30% and reduced cortical NFT burden by ≥25% in CX3CL1-overexpressing P301S mice relative to littermate controls | — no observation — | pending | 0.65 |
| IF we administer an anti-TREM2 agonistic antibody (to enhance TREM2 signaling) combined with CX3CL1 overexpression in P301S mice, THEN we will observe synergistic enhancement of tau clearance (measure | Synergistic reduction in cortical Sarkar score or AT8-positive neuron count: combination group shows ≥2-fold greater tau clearance than CX3CL1-only or TREM2 Ab- | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF we selectively overexpress CX3CL1 in cortical excitatory neurons of P301S tauopathy mice (via viral vector or transgenic approach), THEN we will observe a statistically significant increase in microglial phagocytosis of extracellular tau aggregates (measured by reduced CSF tau concentration or re
Predicted outcome: Reduced CSF total tau by ≥30% and reduced cortical NFT burden by ≥25% in CX3CL1-overexpressing P301S mice relative to littermate controls
Falsification: No significant difference in tau aggregate burden or CSF tau levels between CX3CL1-overexpressing mice and controls, or increased rather than decreased tau pathology, would falsify the prediction that
pendingconf 55%
IF we administer an anti-TREM2 agonistic antibody (to enhance TREM2 signaling) combined with CX3CL1 overexpression in P301S mice, THEN we will observe synergistic enhancement of tau clearance (measured by ≥50% reduction in cortical tau tangles) beyond either intervention alone within 16 weeks, compa
Predicted outcome: Synergistic reduction in cortical Sarkar score or AT8-positive neuron count: combination group shows ≥2-fold greater tau clearance than CX3CL1-only or
Falsification: Combination therapy does not produce significantly greater tau clearance than the better single-agent arm (p>0.05 by two-way ANOVA interaction term), indicating lack of synergistic interaction and sug
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.